Cargando…

Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species

Coronaviruses M proteins are well-represented in the major protein component of the viral envelope. During the viral assembly, they play an important role by association with all other viral structural proteins. Despite their crucial functions, very little information regarding the structures and fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Alharbi, Sultan Nafea, Alrefaei, Abdulwahed Fahad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787911/
https://www.ncbi.nlm.nih.gov/pubmed/33432259
http://dx.doi.org/10.1016/j.jksus.2020.101335
_version_ 1783632925336535040
author Alharbi, Sultan Nafea
Alrefaei, Abdulwahed Fahad
author_facet Alharbi, Sultan Nafea
Alrefaei, Abdulwahed Fahad
author_sort Alharbi, Sultan Nafea
collection PubMed
description Coronaviruses M proteins are well-represented in the major protein component of the viral envelope. During the viral assembly, they play an important role by association with all other viral structural proteins. Despite their crucial functions, very little information regarding the structures and functions of M proteins is available. Here we utilize bioinformatic tools from available sequences and 3D structures of SARS-CoV, SARS-CoV2, and MERS-CoV M proteins in order to predict potential B-cell epitopes and assessing antibody binding affinity. Such study aims to aid finding more effective vaccines and recognize neutralizing antibodies. we found some rather exciting differences between SARS-COV-2, SARS-Cov and MERS-CoV M proteins. Two SARS-CoV-2 peptides with significant antigen presentation scores for human cell surface proteins have been identified. The results reveal that N-terminal domains of M proteins of SARS-CoV and SARS-CoV2 are translocated (outside) whereas it is inside (cytoplasmic side) in MERS-CoV.
format Online
Article
Text
id pubmed-7787911
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
record_format MEDLINE/PubMed
spelling pubmed-77879112021-01-07 Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species Alharbi, Sultan Nafea Alrefaei, Abdulwahed Fahad J King Saud Univ Sci Original Article Coronaviruses M proteins are well-represented in the major protein component of the viral envelope. During the viral assembly, they play an important role by association with all other viral structural proteins. Despite their crucial functions, very little information regarding the structures and functions of M proteins is available. Here we utilize bioinformatic tools from available sequences and 3D structures of SARS-CoV, SARS-CoV2, and MERS-CoV M proteins in order to predict potential B-cell epitopes and assessing antibody binding affinity. Such study aims to aid finding more effective vaccines and recognize neutralizing antibodies. we found some rather exciting differences between SARS-COV-2, SARS-Cov and MERS-CoV M proteins. Two SARS-CoV-2 peptides with significant antigen presentation scores for human cell surface proteins have been identified. The results reveal that N-terminal domains of M proteins of SARS-CoV and SARS-CoV2 are translocated (outside) whereas it is inside (cytoplasmic side) in MERS-CoV. The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2021-03 2021-01-07 /pmc/articles/PMC7787911/ /pubmed/33432259 http://dx.doi.org/10.1016/j.jksus.2020.101335 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Alharbi, Sultan Nafea
Alrefaei, Abdulwahed Fahad
Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
title Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
title_full Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
title_fullStr Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
title_full_unstemmed Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
title_short Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
title_sort comparison of the sars-cov-2 (2019-ncov) m protein with its counterparts of sars-cov and mers-cov species
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787911/
https://www.ncbi.nlm.nih.gov/pubmed/33432259
http://dx.doi.org/10.1016/j.jksus.2020.101335
work_keys_str_mv AT alharbisultannafea comparisonofthesarscov22019ncovmproteinwithitscounterpartsofsarscovandmerscovspecies
AT alrefaeiabdulwahedfahad comparisonofthesarscov22019ncovmproteinwithitscounterpartsofsarscovandmerscovspecies